Extent of the deficitary form in resistant schizophrenia;Part de la forme deficitaire dans la schizophrenie resistante

Encephale

Volumn 22, Issue SPEC. ISS. 2, 1996, Pages 19-23

  Samuelian, J C ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

deficitary schizophrenia; negative symptoms; positive symptoms; resistant schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

CONFERENCE PAPER; DRUG RESISTANCE; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; NEGATIVE SYNDROME; SCHIZOPHRENIA; SOCIAL BEHAVIOR; CHRONIC DISEASE; CLASSIFICATION; DEPRESSION; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; REVIEW; TREATMENT FAILURE;

ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; DEPRESSION; HUMANS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT FAILURE;

EID: 0029815518     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. ANDREASEN NC, OLSEN S. Negative versus positive schizophrenia. Definition and validation. Arch Gen Psychiatry 1982; 39, 7: 789-94.
2. ANDREASEN NC. Scale for the Assessment of Positive Symptoms (SAPS). University of Iowa, Iowa city. Traduction française P. Boyer, Y. Lecrubier, 1987. Fiche descriptive et traduction française de la SAPS. Psychiatr Psychobiol 1983; 2, 6: 425-37.
3. ARNDT S, ALLIGER RJ, ANDREASEN NC. The distinction of positive and negative symptoms. The failure of a two-dimensional model. Br J Psychiatry 1991; 158: 317-22.
4. e Congrès mondial de Psychiatrie, 1993: 34-5.
5. BILDER RM, MURKHERJEE S, RIEDER RO et al. Symptomatic and neuropsychological components of defect states. Schizophr Bull 1985; 11: 409-19.
6. BLEULER E. Dementia Praecox oder Gruppe der Schizophrenien. In: Aschaffenburg g. (Hrsg). Handbuch der Psychiatrie. Leipzig-Wien: Deuticke F, 1911. English translation by Zinkin J.: Dementia Praecox or the group of schizophrenias. New York: International University Press, 1950. Traduction française résumée par H. Ey en 1926, Cercle d'Études Psychiatriques, texte ronéotypé, 1964.
7. BRENNER, DENCKER SJ, GOLDSTEIN G. Defining treatment refractoriness in schizophrenia. Schizophr Bull 1990; 16: 551-61.
8. CARPENTER WT, DOUGLAS Jr, HEINRICHS W, WAGMAN AM. Deficit and nondeficit forms of schizophrenia: the concept . Am J Psychiatry, May 1988; 145: 5.
9. CASTLE, MURRAY. The neurodevelopment basis of sex differences in schizophrenia. Psychol Med 1991; 21: 565-75.
10. COLE JO, GOLDBERG SC, DAVIS JM. Drugs in the treatment of psychosis: controlled studies. Psychiatric Drugs 1966: 153-80.
11. CROW TJ. Molecular pathology of schizophrenia: more than one disease process ? Br Med J 1980; 6207 (280): 66-8.
12. CROW TJ. The two-syndrome concept: origins and current status. Schizophr Bull 1985; 11: 471-86.
13. GOLDBERG SC. Negative and deficit symptoms in schizophrenia do respond to neuroleptics. Schizophr Bull 1985; 11: 453-6.
14. HUBER G. Pneumencephalographische und psychopathologische Bilder bei endogenen Psychosen. Berlin: Springer, 1957.
15. HURET JD. Les pensées de la schizophrénie. Synapse 1987; 32: 42-7.
16. JOHNSTONE EC, CROW TJ, FRITH CD, CARNEY MWP, PRICE JS. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet 1978: 848-51.
17. KANE JM. The current status of neuroleptic therapy. J Clin Psychiatry 1989; 50: 322-328.
18. KAY SR, OPLER LA, LINDENMAYER JP. The positive and negative syndrome scale (PANSS); rationale and standardisation. Br J Psychiatry 1989; 155 Suppl 7: 59-67.
19. KAY SR, SINGH MM. The positive-negative distinction in drug-free schizophrenic patients. Arch Gen Psychiatry 1989; 46, 8: 711-8.
20. KAY SR. Signifiance of the positive-negative distinction in schizophrenia. Schizophr Bull 1990; 16, 4: 635-52.
21. KAY SR, OPLER LA. The positive-negative dimension in schizophrenia: its validity and significance. Psychiatr Dev 1987; 5: 79-103.
22. KULHARA P, KOTA SK, JOSEPH S. Positive and negative subtypes of schizophrenia: a study from India. Acta Psychiatr Scand 1986; 74: 353-9.
23. LEWIN RJ, FOGG L, MELTZER HY. Assessment of negative and positive symptoms in schizophrenia. Schizophr Bull 1983; 9: 368-76.
24. MAIER W, SCHLEGEL S, KLINGER T, HILLERT A, WETZEL H. Die negativ-symptomatik im Verhältnis zur positiv-symptomatik und zur depressiven Symptomatik der Schizophrenie: Eine psychometrische Untersuchung. Neure Ansätze zur diagnostik und Therapie schizophrener Minussymptomatik. Berlin: Springer, 1990: 69-78.
25. MELTZER HY, SOMMERS AA, LUCHINS DJ. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia. J Clin Psychopharmacol 1986; 6: 329-338.
26. MÖLLER HJ. Neuroleptic treatment of negative symptoms in schizophrenic patients. Efficacy problems and methodological difficulties. Europ Neuropsychopharmacol 1993; 3: 1-11.
27. e Congrès Mondial de Psychiatrie 1993, 19.
28. SOMMERS AA. Negative symptoms: conceptual and methodological problems. Schizophr Bull 1985; 11: 364-79.
29. STRAUSS JS, CARPENTER WT. Mediating process in schizophrenia. Toward a new dynamic psychiatry. Br J Psychiatry 1972; 155(suppl. 5):22-8.
30. VANELLE JM, BROCHIER T. Les schizophrénies résistantes. Paris: Massen, 1994.